Helala AlShehri | Cancer Genetics | Research Excellence Award

Published on by Genetics and Genomics

Assist. Prof. Dr. Helala AlShehri | Cancer Genetics | Research Excellence Award

Jubail Industrial College | Saudi Arabia

Assist. Prof. Dr. Helala Mohammad AlShehri is an Assistant Professor of Computer Science and Deputy for Planning and Development at Jubail Industrial College, Saudi Arabia. She earned her PhD in Computer Science from King Saud University and brings together strong academic leadership with advanced research expertise in artificial intelligence and deep learning. Dr. AlShehri has held several senior administrative roles, including department chair and head of student and academic affairs, contributing significantly to institutional planning, quality assurance, and academic accreditation. Her research focuses on AI-driven medical image analysis, particularly histopathological image classification for cancer diagnosis, explainable AI, and computer-aided decision support. She has published nine peer-reviewed articles in SCI- and Scopus-indexed journals, with over 140 citations. Dr. AlShehri actively collaborates with national and international researchers and serves as a peer reviewer for leading AI and medical imaging journals.

Citation Metrics (Scopus)

1000
100
10
5
0

Citations
97

Documents
6

h-index
5

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile View Google Scholar Profile

Featured Publications

Yuhui Sun | Gene Therapy | Excellence in Research

Published on by Genetics and Genomics

Prof. Dr. Yuhui Sun | Gene Therapy | Excellence in Research

Huazhong University of Science and Technology | China

Prof. Dr. Yuhui Sun is a Professor at Huazhong University of Science and Technology, China. He received his Ph.D. from Shanghai Jiao Tong University and conducted postdoctoral research at the University of Cambridge in Professor Peter F. Leadlay’s group. He served as a Professor at Wuhan University before joining HUST. His research focuses on microbial natural product discovery, biosynthesis, and the development of advanced genetic and genome-editing tools, particularly CRISPR-Cas9–based base editors. Professor Sun has led eight major national and provincial research projects, published 69 SCI-indexed papers with an H-index of 25 and over 1,900 citations, authored a Springer Nature book chapter, and holds nine international and Chinese patents. He has extensive industry collaboration experience, serves on multiple international editorial boards, and is a Fellow of the Royal Society of Chemistry (UK). Internationally recognized for elucidating complex biosynthetic mechanisms and creating hybrid microbial medicines, he has also developed widely adopted genome-editing technologies shared with over 80 research groups worldwide.

Citation Metrics (Scopus)

2400
1800
1200
  600
  0

Citations
2,070

Documents
72

h-index
27

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile

Featured Publications

Changcai Teng | Molecular genetics | Research Excellence Award

Published on by Genetics and Genomics

Prof. Dr. Changcai Teng | Molecular genetics | Research Excellence Award

Academy of Agriculture and Forestry, Qinghai university | China

Prof. Dr. Changcai Teng, born on 27 May 1982, is a Chinese crop genetics and breeding specialist currently serving as a Faba Bean Breeder at the Qinghai Academy of Agriculture and Forestry Science and Qinghai University’s Academy of Agriculture and Forestry. He holds a PhD (2018) and MSc (2009) in crop genetics and breeding, as well as a postgraduate qualification in forestry science (2004), all from Qinghai University in Xining, China. With professional experience spanning roles at the Agricultural Technology Promotion Center in Gonghe County and the Sino-Canada joint venture Jason Group Corporation Luyuan Ecology Co., Ltd, his research has focused on the genetics and breeding of Spring Brassica napus, potato, and faba bean. Proficient in Chinese and English, he is based in Xining, Qinghai Province.

Profiles: Scopus 

Featured Publications

"Genome-wide identification of the MADS-box gene family and their role in the formation of faba bean (Vicia faba L.) growth habits", Prof. Dr. Changcai Teng., 2025

Hanyurwumutima Egide | Molecular Genetics | Best Scholar Award

Published on by Genetics and Genomics

Dr. Hanyurwumutima Egide | Molecular Genetics | Best Scholar Award

Graduate School of Chinese Academy of Agricultural Sciences/ Burundi Institute of Agricultral Sciences | Burundi

Dr. Hanyurwumutima Egide, a Veterinary Doctor of Burundian and Rwandan nationality, is an accomplished researcher and animal health professional with extensive experience in veterinary services, food safety, and livestock development. Since January 2016, he has served as a Researcher and National Animal Health Officer at the Burundi Institute of Agricultural Sciences and Research (ISABU), where he leads research initiatives, supports animal health management, provides extension services, and contributes to food safety programs. He also acted as the Burundi Facilitator for the Healthy Animal–Safe Food Program (ITP) supported by the Swedish International Cooperation Development Agency from 2018 to 2023, organizing regional activities and training participants in Sweden. As Chef of ISABU in the PADAIGL and LEAF (ADRA) projects, he established 200 bee and goat cooperatives, created 100 Farmer Field Schools, and trained farmers in livestock and environmental adaptation practices. His earlier roles include serving as Adviser in the Direction de la Promotion des Filières Animales, focusing on animal genetic resource improvement, fish production, and apiculture; Chef of Animal Health for Kayanza Province; and field veterinary officer at Cibitoke Ambulatory Veterinary Pharmacy.

Profiles: Scopus 

Featured Publications

"Prevalence of pathogenic bacteria and their antimicrobial patterns analysis of clinical samples from free-range chickens raised in forest farms in Zhouqu county of Gansu Province, China", Hanyurwumutima Egide ,2025.

Yong Xu | Cartilage Tissue | Best Researcher Award

Published on by Genetics and Genomics

Dr. Yong Xu | Cartilage Tissue | Best Researcher Award

Tongji University | China

Author Profile

Scopus

✨ XU YONG: A PIONEER IN TUMOR TREATMENT AND TISSUE REPAIR ✨

🎓 EARLY ACADEMIC PURSUITS

Xu Yong was born on May 29, 1991, in Fuzhou, Jiangxi, and pursued a career in medicine from an early age. He embarked on his academic journey at Tongji University School of Medicine, where he obtained his Bachelor of Clinical Medicine (2010-2015). With a keen interest in thoracic surgery and tissue engineering, he continued his education at Shanghai Pulmonary Hospital, earning a Master's Degree in Thoracic Surgery (2015-2018). His academic dedication led him to pursue a Ph.D. in Thoracic Surgery (2018-2021) at the same institution, where he developed expertise in tumor treatment and tissue repair.

🌟 PROFESSIONAL ENDEAVORS

Following his Ph.D., Xu Yong joined Shanghai Pulmonary Hospital as a Resident Physician (2021-2024), where he honed his clinical skills in thoracic surgery and tissue engineering. In August 2024, he transitioned to a research-focused role as a Special Associate Researcher at the Nuclear Industry 416 Hospital, Provincial Clinical Medical Research Center. His work in this position is instrumental in advancing innovative solutions for tracheal tissue engineering and regenerative medicine.

⚖️ CONTRIBUTIONS AND RESEARCH FOCUS ON CARTILAGE TISSUE

Xu Yong’s research primarily revolves around tissue engineering for cartilage regeneration, with a strong emphasis on functional tracheal reconstruction. His groundbreaking work introduced the "ring strategy", which enables the construction of bionic tracheal tissue with an alternating cartilage ring-connective tissue ring arrangement. This strategy successfully demonstrated long-term functional reconstruction of long-segment tracheal defects in rabbit models.

⚛️ MAJOR RESEARCH PROJECTS

Xu Yong has been the Principal Investigator (PI) in multiple prestigious projects, including:

  • Shanghai Science and Technology Rising Star Project (2024-2027): Focused on high-bionic tracheal tissue engineering (400,000 RMB).
  • Youth Talent Support Project (2023-2025): Dedicated to tracheal tissue engineering (300,000 RMB).
  • National Natural Science Foundation of China (2024-2026): Developing simulated tracheal tissue for large animal models (300,000 RMB).
  • Shanghai Natural Science Foundation (2022-2025): Advancing the construction of bioengineered trachea (200,000 RMB).

Additionally, he is a key participant in a major project funded by the National Natural Science Foundation of China (2,150,000 RMB), focusing on the precise matching of multiple cell types for bionic construction of long-segment trachea.

✨ IMPACT AND INFLUENCE

Xu Yong’s contributions have significantly influenced the field of tissue engineering and regenerative medicine, particularly in tracheal defect repair. His innovative biomimetic tracheal tissue construction has paved the way for improved clinical applications in treating long-segment tracheal defects. His research bridges the gap between basic science and clinical translation, offering promising therapeutic solutions for thoracic surgery.

🏆 ACADEMIC CITATIONS AND PUBLICATIONS

Xu Yong has an impressive publication record, contributing to over 30 SCI papers with a cumulative impact factor exceeding 300. His key achievements include:

  • 20 papers as first/co-first author
  • 14 papers as corresponding/co-corresponding author
  • 15 papers with an impact factor greater than 10
  • Highest single impact factor: 27.4

Notable journals where his research has been published:

  • Advanced Materials (ADV MATER)
  • Advanced Functional Materials (Adv. Funct. Mater.)
  • Advanced Science (Adv Sci.)
  • Composites Part B: Engineering (COMPOS PART B-ENG)
  • International Journal of Bioprinting (INT J BIOPRINTING)

Additionally, he holds over 10 patents related to tissue engineering and regenerative medicine.

🎬 LEGACY AND FUTURE CONTRIBUTIONS

Xu Yong’s pioneering efforts in tracheal tissue engineering and tumor treatment have established a new benchmark in the field. His ring strategy has set the foundation for future research in biomimetic tracheal reconstruction. Moving forward, he aims to:

  • Advance clinical translation of biomimetic tracheal tissue into human trials.
  • Explore novel biomaterials and tissue engineering scaffolds.
  • Collaborate on interdisciplinary projects integrating AI-driven biomaterial development.

His contributions will continue to shape the future of thoracic surgery, offering lifesaving solutions for patients with severe tracheal defects.

✨ CONCLUSION

Xu Yong is a trailblazer in regenerative medicine and thoracic surgery, whose dedication to tissue engineering and tracheal reconstruction has the potential to revolutionize the field. With a solid foundation in research, clinical expertise, and a vision for innovation, he is poised to make lasting contributions to modern medicine.

📑 NOTABLE PUBLICATIONS 

"Cartilage structure-inspired nanofiber-hydrogel composite with robust proliferation and stable chondral lineage-specific differentiation function to orchestrate cartilage regeneration for artificial tracheal construction" 

  • Authors: Y., Li, Yaqiang , X., Xun, Xiaowei , L., Duan, Liang , Y., Xu, Yong , H., Xia, Huitang
  • Journal: Bioactive Materials
  • Year: 2025

"Polydopamine-loaded microneedles for sequential tumor ablation and osteochondral regeneration" 

  • Authors: B., Lin, Bin , Y., Xu, Yong , B., Liang, Bing
  • Journal: Materials Letters
  • Year: 2025

"Copper hydrogen phosphate nanosheets functionalized hydrogel with tissue adhesive, antibacterial, and angiogenic capabilities for tracheal mucosal regeneration" 

  • Authors: P., Wang, Pengli , E., Gao, Erji , T., Wang, Tao , C., Yang, Chen , L., Duan, Liang
  • Journal: Journal of Nanobiotechnology
  • Year: 2024

"3D printing of Ceffe-infused scaffolds for tailored nipple-like cartilage development" 

  • Authors: J., Ding, Jinghao , C., Wei, Chuanzhi , Y., Xu, Yong , W., Dai, Wufei , R., Chen, Ru
  • Journal: BMC Biotechnology
  • Year: 2024

"Injectable and self-healing sulfated hyaluronic acid/gelatin hydrogel as dual drug delivery system for circumferential tracheal repair" 

  • Authors: Y., Yang, Yayan , X., Zhu, Xinsheng , X., Liu, Xuezhe , N., Song, Nan , Q., Feng, Qian
  • Journal: International Journal of Biological Macromolecules
  • Year: 2024

Sidra Batool | DNA Sequencing | Women Researcher Award 

Published on by Genetics and Genomics

Dr. Sidra Batool | DNA Sequencing | Women Researcher Award 

Abdul Wali Khan University Mardan | Pakistan

Author Profile

Scopus 

📜 SIDRA BATOOL: A DEDICATED RESEARCHER AND LEADER

🎓 EARLY ACADEMIC PURSUITS

Sidra Batool, born on January 30, 1997, in Kohat, Khyber Pakhtunkhwa, Pakistan, has pursued a solid academic career. She completed her Matriculation in 2014 with an A1 grade from the BISE Kohat. Continuing her journey, she earned her Intermediate qualification in 2016, achieving an A grade from the BISE Kohat. Her academic foundation, especially in sciences, laid the groundwork for her future research endeavors.

💼 PROFESSIONAL ENDEAVORS

Sidra has demonstrated a diverse range of experiences across academia and business. She has worked as a Research Assistant under Prof. Dr. Sadaf Niaz in the Department of Zoology at Abdul Wali Khan University Mardan. Her key responsibilities included conducting Field Surveys, performing DNA Extraction, PCR Sequencing, and Bioinformatics Analysis. This hands-on experience with advanced laboratory techniques enabled her to contribute significantly to the understanding of tick infestations and related biosecurity measures.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DNA SEQUENCING

Sidra’s primary research focuses on molecular biology, toxicology, and bioinformatics. Her work emphasizes the taxonomic and molecular characterization of ticks, along with the ecological impacts of various species on livestock. This research is crucial for understanding and controlling tick-borne diseases, especially in rural and under-researched regions of Pakistan. She is proficient in a variety of advanced laboratory techniques, including DNA Extraction, Gel Electrophoresis, PCR, and bioinformatics tools like R Programming, Python, BioEdit, and BEAST. Sidra has also made notable contributions to genomic databases, with several GenBank submissions to her credit, such as OR665376.1, PP565365.1, and PP477083.1.

🌍 IMPACT AND INFLUENCE

Sidra’s research has a direct impact on the field of zoology, particularly in understanding tick infestations and improving livestock health in Pakistan. Her work contributes to sustainable livestock management, helping rural communities mitigate the risks posed by pathogens. Her technical expertise in bioinformatics and molecular biology enables her to explore the genomics of species that directly affect public health and the agricultural economy. Additionally, Sidra’s leadership qualities are evident as she currently manages a team of four, further solidifying her role as a guide and mentor for younger researchers.

🏅 ACADEMIC CITES

Sidra Batool has already started to make her mark in the academic world, with her work receiving citations across various research publications and genomic repositories. Her GenBank submissions and collaborative research papers reflect her growing academic influence. Her participation in conferences and seminars has allowed her to present her findings on a national level, further expanding her recognition in the scientific community.

🏛️ LEGACY AND FUTURE CONTRIBUTIONS

Sidra’s legacy will be defined by her commitment to molecular biology and her efforts to advance research in tick-borne diseases, biosecurity, and ecological conservation. As a young researcher, her potential for contributing to both academic and practical solutions in the field of zoology is immense. In the future, Sidra aspires to expand her research beyond the borders of Pakistan, focusing on international collaborations that address global challenges in zoonotic diseases and biosecurity. With her solid academic background, practical experience, and leadership qualities, she is well-positioned to contribute to global scientific advancements.

✨ PERSONAL SKILLS AND ACHIEVEMENTS

Sidra is proficient in multiple languages, including Pashto, Urdu, and English. Her strong communication skills, both in written and spoken formats, complement her ability to present complex scientific data clearly. She has also garnered a fully funded scholarship through the Ehsaas Undergraduate Scholarship Program for her bachelor’s studies, underscoring her academic excellence. Sidra’s diverse skill set extends to computational tools, where she excels in software like Microsoft Office, FinchTV, Latex, Mesquite, and Figtree, adding value to her research in bioinformatics and computational biology.

📑NOTABLE PUBLICATIONS 

“Infestation prevalence, spatio-temporal distribution, phylogenetic positioning, and pathogen investigation of Argas persicus ticks in domestic hens (Gallus gallus domesticus) from Pakistan” 

  • Authors: Tsai, K.-H., Batool, S., Khan, A.,  Ben Said, M., Khan, A.
  • Journal: Veterinary Parasitology
  • Year: 2024

Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Published on by Genetics and Genomics

Dr. Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Chungna National University | South Korea

Author Profile 

Scopus

Google Scholar

BIOGRAPHY OF SANG YEON CHO 🌟

EARLY ACADEMIC PURSUITS 🎓

Sang Yeon Cho embarked on his academic journey at Chungnam National University, where he earned his Bachelor's degree in Biochemistry in 2012. He further pursued an M.S. in Medicine, obtaining his MD degree in 2021. Currently, he is completing his Ph.D. in New Drug Discovery and Development, expected to graduate in February 2025. His strong foundation in the sciences has equipped him with the skills necessary for innovative research in the medical field.

PROFESSIONAL ENDEAVORS 🏥

Currently, Dr. Cho serves as the Vice Director of the Metro Neurosurgery Clinic in Daejeon, South Korea, since October 2022. Prior to this role, he was the Vice Director of Hurisarang Hospital from March 2021 to September 2022. His leadership positions reflect his commitment to advancing medical practice and enhancing patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR CANCER BIOLOGY 🔬

As the Director of ChoLab since 2018, Dr. Cho has focused on cancer genomics and new drug discovery. His research has investigated the molecular mechanisms underlying cancer, emphasizing drug resistance and therapeutic targets. He has actively contributed to several labs, including the Neuroglia Lab and the Nano Primo Research Center, showcasing his multidisciplinary approach to tackling complex medical challenges.

IMPACT AND INFLUENCE 🌍

Dr. Cho's work has significantly influenced the field of medical genetics and cancer research. His publications in high-impact journals highlight the clinical significance of his findings, making substantial contributions to understanding cancer prognosis and treatment. Through his research, he aims to bridge the gap between laboratory discoveries and clinical applications, improving patient outcomes.

ACADEMIC CITATIONS 📚

His research output includes numerous peer-reviewed articles in respected journals such as BMC Medical Genomics, Scientific Reports, and BMC Cancer, where he explores topics like drug resistance, immunotherapy biomarkers, and cancer prognosis. His findings have garnered attention and citations within the academic community, underscoring the relevance and quality of his work.

LEGACY 🏆

Dr. Cho's dedication to advancing cancer research and patient care has already left a mark on the field. His innovative approach, exemplified by multiple patents related to AI in healthcare and cancer diagnostics, positions him as a forward-thinking researcher poised to shape future developments in medical science.

FUTURE CONTRIBUTIONS 🔮

Looking ahead, Dr. Cho aims to continue his research in cancer treatment and drug discovery, integrating cutting-edge technologies like artificial intelligence to enhance therapeutic strategies. With his expected Ph.D. completion in 2025, he is set to further expand his contributions to the field and inspire the next generation of medical researchers.

NOTABLE PUBLICATIONS 📑

"A method for the observation of the primo vascular system in the thoracic duct of a rat" 

  • Authors: Kim, S., Jung, S.J., Cho, S.Y., Soh, K.-S., Kim, S.
  • Journal: Evidence-based Complementary and Alternative Medicine
  • Year: 2013

"Protocol for the Observation of the Primo Vascular System in the Lymph Vessels of Rabbits" 

  • Authors: Jung, S.J., Cho, S.Y., Bae, K.-H., ... Song, Y.-K., Soh, K.-S.
  • Journal:  Journal of Acupuncture and Meridian Studies
  • Year: 2012

Sara Salvador | Pharmacogenomics and Personalized Medicine | Best Researcher Award

Published on by Genetics and Genomics

Dr. Sara Salvador | Pharmacogenomics and Personalized Medicine | Best Researcher Award

Gregorio Maranon University Hospital | Spain

Author Profile

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Since 2017, I have been dedicated to advancing the field of pharmacogenetics, beginning as a research assistant and progressing through to postdoctoral researcher at the Pharmacogenetics Laboratory of the Gregorio Marañón General University Hospital. My journey started with foundational research roles and evolved into leadership positions within various pharmacogenomic studies.

PROFESSIONAL ENDEAVORS

Starting as a research assistant, I gradually transitioned to roles as a predoctoral and postdoctoral researcher, accumulating invaluable experience and expertise in pharmacogenetics. My work has been primarily focused on pharmacogenomic studies in diverse medical areas such as colorectal cancer, multiple sclerosis, psychiatry, and intestinal inflammatory diseases.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENMICS AND PERSONALIZED MEDICINE

Throughout my career, I have actively contributed to 21 publications in pharmacogenomics, with a particular emphasis on colorectal cancer, multiple sclerosis, psychiatry, and intestinal inflammatory diseases. Of these publications, I served as the first author for 14, showcasing my significant contributions to the field. Notably, my doctoral thesis in 2020 centered on intestinal inflammatory disease, underscoring my commitment to advancing knowledge in this area.

IMPACT AND INFLUENCE

My contributions have not gone unnoticed, as evidenced by receiving the AEFA (Spanish Clinical Laboratory Association) award for quality and innovation in 2019. Additionally, my research has been recognized through presentations at 20 national and international conferences, including 5 oral communications. I have been honored with the best oral communication award at three conferences, highlighting the impact of my work.

ACADEMIC CITES

My research has contributed to the academic discourse, with citations in various publications, further validating the significance and influence of my work in pharmacogenetics awards and related fields.

LEGACY AND FUTURE CONTRIBUTIONS

As an active member of the Spanish Society of Pharmacogenetics awards and the Spanish Association of Human Genetics, I continue to contribute to the advancement and dissemination of knowledge in these critical areas of public health. My ongoing commitment to research and collaboration ensures that my contributions will continue to shape the future of pharmacogenetics.

NOTABLE PUBLICATIONS

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children 2023(3)

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease 2023(7)

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort 2023(7)

Genotyping of UGT1A1*80 as an Alternative to UGT1A1*28 Genotyping in Spain 2022(5)

Pharmacogenetics to avoid adverse reactions in cardiology: Ready for implementation? 2021(4)

Jian Luo | Immunogenetics and Autoimmune Diseases | Best Researcher Award

Published on by Genetics and Genomics

Dr. Jian Luo | Immunogenetics and Autoimmune Diseases | Best Researcher Award

University of Oxford | United Kingdom

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Jian Luo embarked on his academic journey at West China School of Medicine, Sichuan University, where he completed his Bachelor of Science in Respiratory Care in 2012. His thirst for knowledge led him to pursue further studies, culminating in a Master of Medicine from the same institution in 2015.

PROFESSIONAL ENDEAVORS

Armed with a solid foundation in respiratory medicine, Jian Luo pursued a dual degree program, earning his M.D. and Ph.D. in Respiratory Medicine from West China School of Medicine, Sichuan University, China, in 2018. His academic pursuits then took him to the prestigious University of Oxford, where he completed a Joint DPhil in Respiratory Medicine Unit, NDM Experimental Medicine, in 2018.

CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNOGENETICS AND AUTOIMMUNE DISEASES

Throughout his career, Jian Luo has focused on advancing our understanding of respiratory diseases, particularly inflammatory airway diseases such as asthma and COPD, as well as respiratory critical care medicine, including acute respiratory distress syndrome (ARDS). His research efforts have delved into various aspects of immunology and clinical medicine, with notable investigations into the mechanisms of steroid resistance in various immune cells, the role of cytokines in eosinophil priming, and the immunological signatures of COVID-19 and Immunogenetics Award, particularly in relation to asthma.

IMPACT AND INFLUENCE

Jian Luo's contributions to the field of respiratory medicine are underscored by his extensive publication record, boasting over 25 peer-reviewed papers with an impressive cumulative impact factor of 406.36. Notably, his work has been recognized in high-impact journals such as Cell, Lancet Respiratory Medicine, and the Journal of Allergy and Clinical Immunology.

ACADEMIC CITATIONS

Jian Luo's research findings have garnered attention within the scientific community, evident in the numerous citations his work has received. His studies have contributed valuable insights into the pathogenesis and treatment of respiratory diseases, earning him recognition as a leading authority in the field.

LEGACY AND FUTURE CONTRIBUTIONS

As a senior immunologist and clinician, Jian Luo's legacy extends beyond his academic achievements to his mentorship of future generations of researchers and clinicians. His continued dedication to advancing respiratory medicine promises to shape the landscape of healthcare, paving the way for improved diagnostics, treatments, and ultimately, better outcomes for patients worldwide.

NOTABLE PUBLICATIONS

Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis 2022(103)

Awake prone positioning for patients with COVID-19-induced acute hypoxemic respiratory failure 2022(3)

IL-1β promotes IL-17A production of ILC3s to aggravate neutrophilic airway inflammation in mice 2023(2)

The use of high-flow nasal cannula in patients with chronic obstructive pulmonary disease under exacerbation and stable phases: A systematic review and meta-analysis 2023(4)

Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation 2023(1)

Spyridon Theofilopoulos | Development Neurobiology | Best Researcher Award

Published on by Genetics and Genomics

Prof. Spyridon Theofilopoulos | Development Neurobiology | Best Researcher Award

Deree-The American College of Greece | Greece

AUTHOR PROFILE

Scopus

Orcid ID

Google Scholar

EARLY ACADEMIC PURSUITS

Spyridon Theofilopoulos embarked on his academic journey with a Bachelor of Science degree in Biochemistry from Imperial College of Science, Technology and Medicine, London, U.K. Following this, he pursued his passion for developmental neurobiology, obtaining his Ph.D. from the same institution. His doctoral research, supervised by Professor Henry F. Bradford, focused on neurotrophic factors in neurotransmitter phenotype determination and neuroprotection in the developing human and rat brain.

PROFESSIONAL ENDEAVORS

Dr. Theofilopoulos has held various academic positions internationally, demonstrating his expertise and commitment to the field. Noteworthy roles include his tenure as a Forskare (Senior Researcher/Assistant Professor) at the Karolinska Institute, Stockholm, Sweden, and as a Sêr Cymru II Rising Star fellow and Associate Professor at Swansea University Medical School, Swansea, U.K. Currently, he serves as a Professor and Instructor at the Biomedical Sciences Department of Deree-The American College of Greece, Athens, Greece.

CONTRIBUTIONS AND RESEARCH FOCUS ON DEVELOPMENT NEUROBIOLOGY

Dr. Theofilopoulos has made significant contributions to the field of developmental neurobiology, particularly in the areas of neuroprotection and neurotransmitter phenotype determination. His collaborative research with Teva Pharmaceuticals during his Ph.D. led to the development of Rasagiline, a novel compound for the treatment of Parkinson’s disease. Moreover, his work at Swansea University resulted in the establishment of the spin-off company CholesteniX Ltd, aiming to develop specific cholesterol metabolites for Amyotrophic Lateral Sclerosis therapy.

IMPACT AND INFLUENCE

Theofilopoulos's research has not only contributed to scientific advancements but has also garnered recognition and accolades. He has been invited as a speaker to numerous conferences and meetings, highlighting the impact of his work in the scientific community. Furthermore, his efforts were acknowledged with awards such as the "Outstanding Research and Innovation collaboration in Medicine, Health and Life Sciences" award in 2022.

ACADEMIC CITATIONS

Dr. Theofilopoulos's work has been cited extensively, indicating its relevance and impact in the scientific community. His publications have appeared in reputable journals, and he has served as a reviewer for various scientific publications, including Scientific Reports, eLife, and Frontiers in Cell and Developmental Biology.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Theofilopoulos's legacy lies in his dedication to advancing knowledge in developmental neurobiology and his commitment to mentoring the next generation of scientists. His research funding awards underscore the importance of his work and pave the way for future discoveries in the field. As he continues his academic journey, his contributions are expected to further shape the landscape of neuroscience research.

NOTABLE PUBLICATIONS

The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features 2021(10)

Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development 2024

Mining for oxysterols in cyp7b1−/− mouse brain and plasma: Relevance to spastic paraplegia type 5 2019(13)

24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo 2019(24)

Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1−/− mouse brain and plasma 2019(29)